Back to Search
Start Over
[Use of recombinant activated factor vii in bronchoalveolar lavage in a case of pulmonary hemorrhage].
- Source :
-
Medicina intensiva [Med Intensiva] 2015 May; Vol. 39 (4), pp. 253-5. Date of Electronic Publication: 2014 Sep 03. - Publication Year :
- 2015
- Subjects :
- Anticoagulants adverse effects
Bronchoscopy
Combined Modality Therapy
Comorbidity
Embolization, Therapeutic
Factor VIIa administration & dosage
Female
Hemoptysis diagnostic imaging
Hemoptysis etiology
Hemoptysis therapy
Hemostatic Techniques
Humans
Middle Aged
Multiple Organ Failure etiology
Pneumonia, Bacterial complications
Postoperative Hemorrhage diagnostic imaging
Postoperative Hemorrhage etiology
Postoperative Hemorrhage therapy
Pseudomonas Infections complications
Recombinant Proteins administration & dosage
Recombinant Proteins therapeutic use
Shock, Septic etiology
Tricuspid Valve Insufficiency surgery
Bronchoalveolar Lavage Fluid
Factor VIIa therapeutic use
Hemoptysis drug therapy
Postoperative Hemorrhage drug therapy
Subjects
Details
- Language :
- Spanish; Castilian
- ISSN :
- 1578-6749
- Volume :
- 39
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Medicina intensiva
- Publication Type :
- Editorial & Opinion
- Accession number :
- 25192918
- Full Text :
- https://doi.org/10.1016/j.medin.2014.06.010